MIRA INFORM REPORT

 

 

Report No. :

312231

Report Date :

16.03.2015

 

IDENTIFICATION DETAILS

 

Name :

FLAMINGO PHARMACEUTICALS LIMITED

 

 

Formerly Known As :

FLAMINGO IMPEX PRIVATE LIMITED

 

 

Registered Office :

7/1, Corporate Park, Sion-Trombay Road, Chembur, Mumbai - 400071, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

12.06.1985

 

 

Com. Reg. No.:

11-036572

 

 

Capital Investment / Paid-up Capital :

Rs. 68.040 Millions

 

 

CIN No.:

[Company Identification No.]

U51900MH1985PLC036572

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMF03725B

 

 

PAN No.:

[Permanent Account No.]

AAACF4211B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

450 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Financial position of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities: “BBB-”

Rating Explanation

Have moderate degree of safety and carry moderate credit risk.

Date

27.01.2015

 

Rating Agency Name

CARE

Rating

Short term bank facilities: “A3”

Rating Explanation

Have moderate degree of safety and carry higher credit risk.

Date

27.01.2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Sanjay Gujar

Designation :

Accounts Manager

Contact No.:

91-22-30009300

Date :

12.03.2015

 

 

LOCATIONS

 

Registered Office :

7/1, Corporate Park, Sion –Trombay Road, Chembur, Mumbai - 400071, Maharashtra, India

Tel. No.:

91-22-30009300

Fax No.:

91-22-25233085

E-Mail :

ashf@giasbm01.vsnl.net.in

ashf@flamingopharma.com

accounts@flamingopharma.com

Website :

http://www.flamingopharma.com

Area :

6767 Sq. ft.

Location :

Owned

 

 

Factory 1 :

R-662, T.T.C. Industrial Area, Rabale, Navi Mumbai - 400071, Maharashtra, India

Tel. No.:

91-22-27695593 / 27696998 / 27694571 / 227607130

Fax No.:

91-22-27693844

E-Mail :

mailfplrbl@vsnl.net.in

Area:

4439 Sq. Mtrs

Location:

Owned

 

 

Factory 2 :

E-28, Taloja Industrial Area, Taloja, Raigad – 410208, Maharashtra, India

Tel. No.:

91-22-27411372 / 65162742

Fax No.:

91-22-27411386

E-Mail :

mailfpltlg@vsnl.net.in

Area:

6480 Sq. Mtrs

Location:

Owned

 

 

Factory 3:

Plot No. NPH – 1, Pharms E-2, Krushnur, District Nanded – 431709, Maharashtra, India

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Ashwin Jethalal Thacker

Designation :

Managing Director

Address :

702, Sabari Aangan, 11th Road, Chembur, Mumbai – 400071, Maharashtra, India

Date of Birth :

13.10.1989

Qualification :

B. Sc. (Hons), DBM, DMM (Bom)

Date of Appointment :

23.06.1986

PAN No.:

AACPT2572L

DIN No :

00048595

 

 

Name :

Mr. Deepak Bhupatrai Goradia

Designation :

Director

Address :

222, Sabari Aangan, 7th Floor, 11th Road, Next to Saraswati Vidyalay, Chembur, Mumbai - 400071, Maharashtra, India

Date of Birth :

09.04.1956

Date of Appointment :

03.09.1997

DIN No :

00058544

 

 

Name :

Mr. Suhas Sadanand Ganpule

Designation :

Director

Address :

236, Pratiksha Building, 3rd Floor, Flat No.10, Borivali (West), Mumbai - 400092, Maharashtra, India

Date of Birth :

25.08.1962

Date of Appointment :

17.11.2009

DIN No :

00179817

 

 

KEY EXECUTIVES

 

Name :

Mr. Murlidharan K.

Designation :

Secretary

Address :

Flat No.103, Building No. 11, Neelam Nagar, Phase II, Mulund (East), Mumbai-400018, Maharashtra, India

Date of Birth :

05.01.1957

Date of Appointment :

01.07.2010

PAN No :

AGEPK5441P

 

 

Name :

Mr. Sanjay Gujar

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

No. of Shares

 

Ashwin Thacker

4163400

Raju Thacker

1895400

Pranay Thacker

722400

Parth Thacker

60

Raechella Murzello

30

Sanjay Gujar

30

Minimed Laboratories Private Limited, India

22650

Rotaline Molekule Private Limited, India

30

Total

6804000

 

 

As on 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

0.33

Directors or relatives of Directors

99.66

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

Products :

Item Code No. (ITC Code)

Product Description

30049063

Ibuprofen With or Without Paracetamolor

30042012

Cephalexincontainingo the Rantibiotics

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Pharmaceutical Products

Countries :

·         South East Asia

·         South Africa

·         Europe

·         Switzerland

·         Middle East

·         Sri Lanka

·         US

·         UK

·         Hongkong

·         London

 

 

Imports :

 

Products :

Raw Material

Countries :

·         China

·         Spain

·         Oman

 

 

Terms :

 

Selling :

Cash and Credit (30 Days/ 60 Days/ 90 Days)

 

 

Purchasing :

Cash and Credit (30 Days/ 60 Days/ 90 Days)

 

PRODUCTION STATUS: NOT AVAILABLE 

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (with Designation):

Not Divulged

Contact Number:

Not Divulged

Since How Long Known:

Not Divulged

Maximum Limit Dealt:

Not Divulged

Experience :

Not Divulged

Remarks :

Not Divulged

 

 

Customers :

End Users and OEM’s

 

Reference:

Not Divulged

Name of the Person (with Designation):

Not Divulged

Contact Number:

Not Divulged

Since How Long Known:

Not Divulged

Maximum Limit Dealt:

Not Divulged

Experience :

Not Divulged

Remarks :

Not Divulged

 

 

No. of Employees :

450 (Approximately)

 

 

Bankers :

Bank Name:

Bank of India

Branch:

Andheri Corporate Banking Br. M. D. I. Building, 28, S. V. Road, Andheri (West), Mumbai - 400058, Maharashtra, India

Name of the Person (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Cash Credit: Rs. 75.000 Millions

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         State Bank of India

 

·         ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India

 

·         State Bank of Mauritius Limited, 101, Raheja Centre, Free Press Journal Marg, Nariman Point, Mumbai - 400021, Maharashtra, India

 

·         Axis Bank Limited, Trishul 3rd Floor Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad - 380006, Gujarat, India

 

·         Central Bank India

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Term loans from banks

( i) First pari passu charge, by way of mortgage, on the movable and immovable assets of the company (excluding current assets on which first charge is given in favour of working capital lenders)

 

ii) Second pari passu charge, by way of hypothecation)

625.818

803.990

Other external commercial borrowings

(Foreign Currency Loans)

491.161

259.959

Loans taken for vehicles

( i) First pari passu charge, by way of mortgage, on the movable and immovable assets of the company (excluding current assets on which first charge is given in favour of working capital lenders) ii) Second pari passu charge, by way of hypothecation)

1.087

2.103

 

 

 

SHORT TERM BORROWINGS

 

 

Rupee term loans from banks

( i) First pari passu charge, by way of mortgage, on the movable and immovable assets of the company

 

(excluding current assets on which first charge is given in favour of working capital lenders) ii) Second pari passu charge, by way of hypothecation)

558.894

342.310

Foreign currency term loans from banks

( i) First pari passu charge, by way of mortgage, on the movable and immovable assets of the company (excluding current assets on which first charge is given in favour of working capital lenders) ii) Second pari passu charge, by way of hypothecation)

69.020

287.547

Total

1745.980

1695.909

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Pravin Sarvaiya and Company

Chartered Accountants

Address :

4, Kermani Building, 1st Floor, Sir P. M. Road, Opposite Citi Bank, Fort, Mumbai – 400001, Maharahstra, India

Income-tax PAN of auditor or auditor's firm :

AAOPS8153J

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and

their relatives :

Flamingo Healthcare Limited

Rotaline Molecule Private Limited

Flamingo Infra Developers Private Limited

Minimed Laboratories Private Limited

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10,000,000

Equity Shares

Rs.10/- each

Rs. 100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6,804,000

Equity Shares

Rs.10/- each

Rs. 68.040 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

68.040

68.040

68.040

(b) Reserves & Surplus

1263.448

1164.831

1019.545

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1331.488

1232.871

1087.585

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1218.066

1166.052

984.033

(b) Deferred tax liabilities (Net)

60.235

61.754

73.025

(c) Other long term liabilities

46.419

8.736

0.000

(d) long-term provisions

3.314

1.379

1.797

Total Non-current Liabilities (3)

1328.034

1237.921

1058.855

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

627.914

629.857

565.423

(b) Trade payables

573.632

458.044

271.019

(c) Other current liabilities

375.792

314.329

201.093

(d) Short-term provisions

8.068

15.214

22.833

Total Current Liabilities (4)

1585.406

1417.444

1060.368

 

 

 

 

TOTAL

4244.928

3888.236

3206.808

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2961.908

812.760

842.570

(ii) Intangible Assets

5.329

11.987

16.315

(iii) Capital work-in-progress

0.000

1914.222

1204.075

(iv) Intangible assets under development

30.805

15.607

1.607

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

22.973

31.958

85.126

(e) Other Non-current assets

0.000

14.216

0.000

Total Non-Current Assets

3021.015

2800.750

2149.693

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

268.086

282.449

245.673

(c) Trade receivables

441.208

332.980

345.292

(d) Cash and cash equivalents

131.689

71.938

74.858

(e) Short-term loans and advances

382.243

399.760

390.552

(f) Other current assets

0.687

0.359

0.740

Total Current Assets

1223.913

1087.486

1057.115

 

 

 

 

TOTAL

4244.928

3888.236

3206.808

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

2725.944

2332.745

2183.234

 

 

Other Income

13.947

8.397

27.768

 

 

TOTAL                                     (A)

2739.891

2341.142

2211.002

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1595.262

1409.210

1253.788

 

 

Purchases of Stock-in-Trade

0.000

0.000

19.084

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

19.872

(6.385)

14.894

 

 

Employees benefits expense

189.522

133.621

155.714

 

 

Other expenses

611.414

536.144

435.172

 

 

Exceptional Items

0.000

0.000

29.509

 

 

TOTAL                                     (B)

2416.070

2072.590

1908.161

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

323.821

268.552

302.841

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

120.796

46.495

91.897

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

203.025

222.057

210.944

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

100.657

56.766

50.489

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                (G)           

102.368

165.291

160.455

 

 

 

 

 

Less

TAX                                                                  (H)

(7.629)

8.676

47.911

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

109.997

156.615

112.544

 

 

 

 

 

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

2640.297

2233.005

2072.146

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

659.524

567.900

310.320

 

 

Components and Spare Parts

0.382

2.342

2.004

 

 

Capital Goods

0.414

124.024

179.746

 

TOTAL IMPORTS

660.320

694.266

492.070

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

16.17

23.02

16.54

 

Expected Sales (2014-2015): Rs. 3000.000 Millions

 

The above information has been parted by Mr. Sanjay Gujar (Accounts Manager)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

4.04

6.71

5.15

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

11.88

11.51

13.87

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.43

8.44

8.02

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.08

0.13

0.15

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.39

1.46

1.42

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.77

0.77

1.00

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

68.040

68.040

68.040

Reserves & Surplus

1019.545

1164.831

1263.448

Net worth

1087.585

1232.871

1331.488

 

 

 

 

long-term borrowings

984.033

1166.052

1218.066

Short term borrowings

565.423

629.857

627.914

Total borrowings

1549.456

1795.909

1845.980

Debt/Equity ratio

1.425

1.457

1.386

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2183.234

2332.745

2725.944

 

 

6.848

16.856

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2183.234

2332.745

2725.944

Profit

112.544

156.615

109.997

 

5.15%

6.71%

4.04%

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG TERM DEBTS

 

Particulars

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

 

 

 

 

Current Maturities of Long Term Debts

121.361

123.758

90.677

 

 

 

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10504887

18/06/2014

800,000,000.00

AXIS TRUSTEE SERVICES LIMITED

AXIS HOUSE, 2ND FLR, BOMBAY DYEING MILLS COMPOUND, PANDURANG BUDHKAR MARG, WORLI, MUMBAI, MAHARASHTRA - 400025, INDIA

C08055766

2

10504882

18/06/2014

1,498,000,000.00

AXIS TRUSTEE SERVICES LIMITED

AXIS HOUSE, 2ND FLR, BOMBAY DYEING MILLS COMPOUND, PANDURANG BUDHKAR MARG, WORLI, MUMBAI, MAHARASHTRA - 400025, INDIA

C08054207

3

10485068

20/03/2014

225,000,000.00

RATNAKAR BANK LIMITED

ONE INDIA BULLS CENTER, TOWER NO. 2, 6TH FLOOR,,
841, SENAPATI BAPAT MARG, LOWER PAREL (WEST), MUMBAI, MAHARASHTRA - 400013, INDIA

C00564765

4

10406540

14/02/2013

70,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B68999895

5

10392667

18/01/2014 *

480,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B95055711

6

10392673

06/12/2012

100,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B64406101

7

10388637

31/10/2012

109,400,000.00

STATE BANK OF MAURITIUS LTD

101, RAHEJA CENTRE, FREE PRESS JOURNAL MARG, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

B62829429

8

10373191

03/08/2012

817,921.00

AXIS BANK LIMITED

TRISHUL 3RD FLOOR OPP SAMARTHESHWAR TEMPLE, LAW GARDEN ELLISBRIDGE, AHMEDABAD, GUJARAT - 380006, INDIA

B56658693

9

10303201

29/06/2011

125,000,000.00

STATE BANK OF MAURITIUS LTD

101, RAHEJA CENTRE, 1ST FLOOR, FREE PRESS JOURNAL ROAD, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

B19182393

10

10261319

13/07/2013 *

155,000,000.00

BANK OF INDIA

ANDHERI CORPORATE BANKING BR, M.D.I.BUILDING, 28,
S.V.ROAD, ANDHERI (WEST), MUMBAI, MAHARASHTRA - 400058, INDIA

B81296139

11

10258658

25/02/2014 *

550,000,000.00

AXIS TRUSTEE SERVICES LIMITED

AXIS HOUSE, 2ND FLR, BOMBAY DYEING MILLS COMPOUND, PANDURANG BUDHKAR MARG, WORLI, MUMBAI, MAHARASHTRA - 400025, INDIA

C00634832

12

10207057

26/02/2010

155,000,000.00

BANK OF INDIA

ANDHERI CORPORATE BANKING BR. M. D. I. BUILDING,
28, S. V. ROAD, ANDHERI (WEST), MUMBAI, MAHARASHTRA
- 400058, INDIA

A81362352

13

90213197

28/05/1998

50,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

14

90212921

22/07/2011 *

621,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH 2ND FLOOR, THE ARCADE, WORLD TRADE CENTRE, CUFFE PARADE, COLABA, MUMBAI, MAHARASHTRA - 400005, INDIA

B19074715

15

90235752

25/11/2004 *

144,000,000.00

STATE BANK OF INDIA

WORLD TRADE CENTER, CUFFE PARADE, MUMBAI, MAHARAS
HTRA, INDIA

-

16

90212593

12/04/1996 *

70,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

17

90212229

06/12/1991

9,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

18

90212072

18/05/1990

5,700,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

19

90211889

22/02/1989

3,200,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

20

90211715

14/12/1987

700,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

21

90211647

18/06/1987

980,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Intercorporate deposits

51.350

51.350

Loans and advances from directors

40.450

40.450

Loans and advances from others

8.200

8.200

Total

100.000

100.000

 

 

BUSINESS PERFORMANCE:

 

Overall revenue for the year grew by a healthy rate of ~ 17%, principally contributed by Taloja plant regaining normal working, and helped further by favourable exchange rates. Exports to semi-regulated markets remained stable Rs. 1700.000 Millions (previous year Rs. 1730.000 Millions).

 

Regulated market share in the turnover rose to 81% with exports from Taloja registering Rs. 1000.000 Millions (previous year Rs. 540.000 Millions). Nanded plant started its regular production from September 2013 and could export products valued ~ Rs. 50.000 Millions Margins showed improvement due to higher capacity utilization.

 

The directors, on a review of the domestic business, decided to keep it suspended.

 

 

NANDED PROJECT:

 

As reported in the last annual report, the Oral Solid Dosage (OSD) Plant commenced its regular production after receiving UKMHRA approval in September 2013 and has started exporting its products. The Plant is undergoing customer audit, for technical and ethical compliances, before site transfer of products and commercialization.

 

The Beta Plant has received its manufacturing licence in July 2014 from local FDA though it was technically complete earlier. It now awaits inspection and approval by regulatory authorities, before commencement of regular operations.

 

The directors feel that both the Plants are subject to compliance checks which have become mandatory, before regular business starts there from and are hopeful that these steps build confidence in the customers with regard to quality assurance.

 

 

SUBSIDIARY IN UK

 

Company’s products have sizeable presence in UK and European markets. In order to strengthen its reliance further on these markets, the company has promoted a Wholly Owned Subsidiary (WOS) in UK with emphasis on market promotion and Market Authorization licence acquisition for the company’s products. The London based establishment is expected to give fillip to marketing efforts, which in turn, will help company build healthy order book position and further, improve the capacity utilization of the plants.

 

US MARKET

 

The company has filed its first ANDA with US FDA in June 2014 and has planned to file more such applications periodically. By this filing, the inspection of Nanded Plant by USFDA has been triggered. Once the facilities and ANDA products are approved, the company will be able to enter US market with its product launch.

 

The company has already set up strong technical and regulatory team to comply with the USFDA regulatory requirements.

 

The management is confident of getting the USFDA approval as and when the inspection is done.

 

 

FINANCE

 

The opportunities to boost formulation export business are abound and therefore, it may be necessary to raise growth capital, at appropriate time, to exploit them. The Directors are seized of the need and will work towards appropriate fund raising strategy, keeping in mind the long term business interests of the company.

 

 

The company has been regular in servicing its debt raised from the banks.

 

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

Bank Guarantees (Sales tax, MSEDCL, etc.)

10.291

10.167

Export Bills Discounted with bank

137.342

80.806

Letter of Credit against import of materials

104.651

34.600

Service tax

24.000

24.000

 

 

FIXED ASSETS

 

Tangible Assets

·         Land

·         Factory Building

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Motor Vehicles

·         Office Equipment

·         Leasehold Improvements

 

Intangible Assets

·         Computer Software

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.67

UK Pound

1

Rs.93.16

Euro

1

Rs.66.42

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.